Some aspects of the epidemiology, clinical manifestations, and diagnosis of human dirofilariasis caused by Dirofilaria repens.

In recent years, zoonotic filariae Dirofilaria immitis and Dirofilaria (Nochtiella) repens are gaining popularity as incidental human parasitic pathogens. The usual hosts for these nematodes are domestic and wild carnivorous animals. The medical significance of human dirofilariasis is due to frequent misdiagnosis as malignancy and in many cases diagnosis is made after invasive surgical procedures. The aim of this study was to ascertain the geographical distribution and clinical manifestations of a relatively rare among people zoonotic disease such as dirofilariasis, whose epidemiological features depends on prevalence of the parasite among usual hosts, presence of suitable vector, and human activities favoring exposure. Data for a 39-year period were analyzed, during which, in Bulgaria, were recorded 47 cases of human dirofilariasis with various organ localizations. Morphological methods were also used for species identification of Dirofilaria (N.) repens and serological diagnostic tests for filariasis. Some epidemiological parameters such as annual incidence, prevalence for different geographic areas in Bulgaria, distribution by gender (28 females and 19 males) and age (from 19 to 77 years of age) of the diseased were identified, and aspects of the clinical manifestations, diagnosis, and treatment of the disease were discussed. Comparison was made between the number of cases in Bulgaria and those in other European countries. Although the climatic and faunal conditions in Bulgaria are favorable for disease transmission between animal reservoir hosts and humans, the diagnosis of dirofilariasis is often omitted.

Clinical features, diagnostic tools, and treatment regimens for visceral leishmaniasis in Bulgaria.

PURPOSE: Visceral leishmaniasis (VL), caused by the parasite Leishmania infantum, which was once largely confined to Southern Europe is now being diagnosed throughout Northern Europe, including Great Britain. In an effort to help EU clinicians improve their diagnosis and management of VL, this paper defines clinical features typical of the disease as it presents in Bulgaria, where VL is endemic. METHODS: The list of clinical symptoms presented here was gleaned from the medical records (patient histories, epidemiological survey cards, laboratory data) of 59 Bulgarian patients with VL. This study also includes microscopic, serological, and molecular laboratory techniques. RESULTS: Described and analyzed are the clinical features, diagnostic techniques, and therapeutic regimens of 59 cases--part of the total number of VL case histories (P = 120, 116 Bulgarian and 4 not Bulgarian) collected in Bulgaria over the past 24 years (1988-2011). Although all of the studied 59 cases presented with classical symptoms of VL, only in three occasions, the initial diagnosis was correct. CONCLUSIONS: Left untreated, zooanthroponotic VL leads to debilitating chronic disease and even death. Yet, because VL is hard to recognize and relatively new to Northern Europe, misdiagnosis is common and treatment too often inappropriate and delayed.